Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Similar documents
Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Supplementary Online Content

Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9

Common Codes for ICD-10

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

Supplementary Appendix

The contractor establishes and maintains a register of patients with AF

Supplementary Online Content

Supplementary Online Content

Supplement materials:

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

SUPPLEMENTAL MATERIALS

Supplementary Online Content

SUPPLEMENTARY MATERIAL

Process Measure: Screening for Adult Obstructive Sleep Apnea

Supplementary Online Content

Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE

SUPPLEMENTAL MATERIAL

Atrial fibrillation patients do not benefit from acetylsalicylic acid

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

ARRHYTHMIAS AND DEVICE THERAPY

S2 File. Clinical Classifications Software (CCS). The CCS is a

Appendix 1: Supplementary tables [posted as supplied by author]

ACOFP 55th Annual Convention & Scientific Seminars. How Complicated is Your Panel? Effective Risk Coding in Primary Care. Alison Mancuso, DO, FACOFP

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form

Outline Pretransplant Essential data Why comorbidities are important? For patients with cancer For patients given allogeneic HCT

Stroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

University of Bristol - Explore Bristol Research

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL

A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12

Cardiology/Cardiothoracic

ischemic stroke, transient ischemic attack, or peripheral artery embolism

17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE

High Risk OSA n = 5,359

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

AF Diagnosis. Incorporated into over 75 health checks and Public Health Checks

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency

Supplementary Online Content

Clinical Study Synopsis

Apixaban for stroke prevention in atrial fibrillation. August 2010

ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular disease

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Downloaded from:

Supplementary Appendix

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

Ischemic Stroke in Critically Ill Patients with Malignancy

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

DECLARATION OF CONFLICT OF INTEREST

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Congestive Heart Failure or Heart Failure

MDGuidelines API: Case Fit v3 Specification 1.3

Apixaban for Atrial Fibrillation in Patients with End-Stage Renal Disease on Dialysis

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

Comorbidity Level 1 Level 2 Level 3 Comments Reference Diabetes Yes Unknown

The Burden of Cardiovascular Disease in North Carolina. Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018

Annual High Claims Survey. Year Ending 31 December 2016

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification

10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62.

Covered Critical Illness Conditions Appendix

Atrial fibrillation: a key determinant in the cardiovascular risk continuum. u Prof. Joseph S. Alpert u Arizona, USA

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

Lipids Testing

Supplementary Online Content

HAS-BLED. Ron Pisters, MD Maastricht University Medical Centre (NL) No conflict of interest

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

CMS Limitations Guide - Cardiovascular Services

Edoxaban For preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (NICE TA 355)

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS:

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Patient Information Last Name: First Name: Middle Initial: Address: City: State: Zip Code:

Anti-thromboticthrombotic drugs

Manuel Castella MD PhD Hospital Clínic, University of

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 patients with diabetes

Troponin I elevation increases the risk of death and stroke in patients with atrial fibrillation a RE-LY substudy. Ziad Hijazi, MD

HEART CONDITIONS IN SPORT

Primary Prevention of Stroke

Chapter 4: Cardiovascular Disease in Patients With CKD

V. Roldán, F. Marín, B. Muiña, E. Jover, C. Muñoz-Esparza, M. Valdés, V. Vicente, GYH. Lip

How a universal health system reduces inequalities: lessons from England

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

References: Murtagh J. Murtagh s General Practice. 5 th edn. Sydney: McGraw Hill; 2010.

Results from RE-LY and RELY-ABLE

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Update overview 2018 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab

Using 3-Digit ICD-9-CM Codes with the Elixhauser Comorbidity Index

Alma Mater Studiorum Università di Bologna

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

Many factors can increase the likelihood of platelets becoming spiky and hyperactive. These include:

ENROLLMENT : Line of Business Summary

Transcription:

Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF symptoms Tachycardia R000 Chest pain R072, R073, R074 Palpitations R002 s Ischaemic stroke I63, I66, I67, unspecified I64 Haemorrhagic stroke I60 I62, I69 Transient ischaemic attack G45 Systemic embolism I74.2 I74.9 Haemorrhages Intracranial bleeding S064 S066 Gastric/duodenal ulcer K25 K28 (subcodes 0 2 and 4 6 only) Any severe bleeding I850, I983, K625, K922 Ischaemic heart disease I20 I25 Heart failure I50, I110, I130, I132, I131, I139 Including dyspnoea R060 Cardiac dysrhythmia I47, I490 I493 Abnormal cardiac conduction I44, I45, I494, I495, Z450, Z950 Valvular disease I05 I091, I33 I39, Q22, Q23 Mitral stenosis I342, I050, I052, Q232 Hypertension I10 I15 Diabetes mellitus E10 E14 s Myocardial infarction I21, I252 Peripheral arterial disease I70 I73 Occlusions I65, I77 Obesity E65 E66 Abnormal renal function N17 N19 (+N28) codes for renal insufficiency, transplantation (Z940, T861) and dialysis (Z49, Z992), E102, I12, I13 Liver disease K70 K77, procedures for liver transplantation or resection Dyslipidaemia E78 Thyroid disease E00 E07 Anaemia D50 D64 Platelet or coagulation defect D65 D69 Lung disease J40 J70, J961 Including emphysema and J43, J44 chronic obstructive pulmonary disease Alcohol-related diagnoses E244, F10, G312, G621, G721, I426, K292, K70, K860, O354, P043, Q860, T51, Y90, Y91, Z502, Z714 Dementia F00 F03 Accidental falls W00 W19, R26 Cancer within preceding 5 years Entire C-series Inflammatory diseases M05 M14, M45, M46, K50 K52, K81, K85 Digestive conditions Entire K-series Rheumatology Entire M-series Ophthalmology Entire H-series Pulmonology Entire J-series 1

Supplementary Table S2 Interactions and multivariable analysis of risk factors for death Interaction Statistical test p Value Age cancer 834 <0.0001 Age renal failure 311 <0.0001 Sex anaemia 212 <0.0001 Age alcohol-related diagnoses 122 <0.0001 Age lung disease 22 <0.0001 All deaths OR (95% CI) OR (95% CI) (including interactions) Age 75 years (vs <65 years) 2.57 (2.47 to 2.68) 3.84 (3.57 4.0) Renal failure* 1.85 (1.81 1.89) 1.84 (1.80 1.88) Cancer 1.81 (1.78 1.85) Cancer age <65 years 5.35 (4.94 5.79) Cancer age 65 74 years 2.88 (2.73 3.05) Cancer age 75 years 1.54 (1.50 1.57) Lung disease* 1.58 (1.55 1.62) 1.57 (1.54 1.60) Age 65 74 years (vs <65 years) 1.37 (1.31 1.44) 1.64 (1.54 1.75) Neurological disease* 1.34 (1.3 1.37) 1.33 (1.29 1.37) Alcohol-related diagnoses 1.32 (1.27 1.37) 1.30 (1.26 1.35) Anaemia* 1.29 (1.26 1.32) 1.28 (1.25 1.31) Heart failure* 1.26 (1.23 1.28) 1.26 (1.23 1.29) Women (vs men) 1.04 (1.02 1.06) 1.02 (1.00 1.04) s* 1.03 (1.0 1.06) 1.04 (1.01 1.06) Thyroid disease* 0.90 (0.87 0.92) 0.90 (0.87 0.92) Hypertension* 0.81 (0.79 0.83) 0.81 (0.79 0.83) *Reference is absent disease or condition. CI, confidence interval; OR, odds ratio. 2

Supplementary Table S3 Characteristics of atrial fibrillation patients hospitalised for heart failure in France in 2012 (n=87 339) (n=8316) Age range, N (%) <65 years 7755 (9) 254 (3) 65 74 years 12 774 (15) 655 (8) 75 years 66 810 (76) 7407 (89) Women, N (%) 44 343 (51) 4300 (52) Alcohol-related diagnosis 5069 (6) 431 (5) Anaemia 23 449 (27) 2887 (35) Cancer 12 483 (14) 1496 (18) Diabetes mellitus 25 006 (29) 2375 (29) Dyslipidaemia 27 040 (31) 2256 (27) Hypertension 65 874 (75) 6288 (76) Inflammatory disease 8733 (10) 1003 (12) Liver failure 4333 (5) 692 (8) Lung disease 22 935 (26) 2688 (32) Neurological disease 7307 (8) 1073 (13) Renal failure 26 947 (31) 3886 (47) Thyroid disease 13 264 (15) 1363 (16) Ischaemic 5129 (6) 498 (6) Haemorrhagic 791 (1) 94 (1) Unspecified 1421 (2) 150 (2) Intracranial 394 (0) 50 (1) Gastrointestinal 1021 (1) 135 (2) Other 791 (1) 94 (1) Systemic embolism 2920 (3) 351 (4) Transient ischaemic attack 2449 (3) 277 (3) Myocardial infarction 9705 (11) 1110 (13) Peripheral artery disease 10 147 (12) 1163 (14) Occlusions 4532 (5) 493 (6) Other ischaemic heart disease 26 187 (30) 2849 (34) Symptoms of AF 7090 (8) 588 (7) Heart failure 39 152 (45) 4916 (59) Cardiac dysrhythmia 7907 (9) 919 (11) Abnormal cardiac conduction 19 619 (22) 2248 (27) Valvular disease/surgery 23 447 (27) 2575 (31) Mitral stenosis 1511 (2) 166 (2) Fall, N (%) 8793 (10) 1218 (15) 3

Supplementary Table S4 Characteristics of atrial fibrillation patients hospitalised for ischaemic stroke in France in 2012 (n=17 295) (n=2614) Age group, N (%) <65 years 2648 (15) 212 (8) 65 74 years 1394 (8) 66 (3) 75 years 13 253 (77) 2336 (89) Women, N (%) 9780 (57) 1612 (62) Alcohol-related diagnosis 795 (5) 109 (4) Anaemia 2535 (15) 499 (19) Cancer 2035 (12) 361 (14) Diabetes mellitus 3788 (22) 601 (23) Dyslipidaemia 5162 (30) 577 (22) Hypertension 12 475 (72) 1927 (74) Inflammatory disease 1310 (8) 202 (8) Liver failure 400 (2) 66 (3) Lung disease 2920 (17) 784 (30) Neurological disease 2139 (12) 412 (16) Renal failure 2561 (15) 570 (22) Thyroid disease 1976 (11) 338 (13) Ischaemic 2057 (12) 310 (12) Haemorrhagic 290 (2) 46 (2) Unspecified 467 (3) 76 (3) Intracranial 120 (1) 17 (1) Gastrointestinal 133 (1) 28 (1) Other 290 (2) 46 (2) Systemic embolism 451 (3) 101 (4) Transient ischaemic attack 849 (5) 104 (4) Myocardial infarction 987 (6) 195 (7) Peripheral artery disease 1178 (7) 270 (10) Occlusions 661 (4) 108 (4) Other ischaemic heart disease 2641 (15) 494 (19) Symptoms of AF 865 (5) 127 (5) Heart failure 3306 (19) 739 (28) Cardiac dysrhythmia 813 (5) 144 (6) Abnormal cardiac conduction 1986 (11) 374 (14) Valvular disease/surgery 1557 (9) 309 (12) Mitral stenosis 103 (1) 20 (1) Fall, N (%) 1669 (10) 364 (14) 4

Supplementary Table S5 Characteristics of atrial fibrillation patients hospitalised for intracranial haemorrhage in France in 2012 (n=1450) (n=335) Age group, N (%) <65 years 185 (13) 25 (7) 65 74 years 86 (6) 7 (2) 75 years 1179 (81) 303 (90) Women, N (%) 603 (42) 138 (41) Alcohol-related diagnosis 120 (8) 24 (7) Anaemia 302 (21) 89 (27) Cancer 219 (15) 63 (19) Diabetes mellitus 325 (22) 84 (25) Dyslipidaemia 343 (24) 82 (24) Hypertension 1043 (72) 239 (71) Inflammatory disease 106 (7) 19 (6) Liver failure 57 (4) 16 (5) Lung disease 252 (17) 87 (26) Neurological disease 250 (17) 57 (17) Renal failure 283 (20) 87 (26) Thyroid disease 184 (13) 33 (10) Ischaemic 99 (7) 30 (9) Haemorrhagic 80 (6) 14 (4) Unspecified 29 (2) 10 (3) Intracranial 118 (8) 14 (4) Gastrointestinal 9 (1) 6 (2) Other 80 (6) 14 (4) Systemic embolism 38 (3) 8 (2) Transient ischaemic attack 54 (4) 11 (3) Myocardial infarction 94 (6) 28 (8) Peripheral artery disease 112 (8) 40 (12) Occlusions 59 (4) 16 (5) Other ischaemic heart disease 277 (19) 72 (21) Symptoms of AF 86 (6) 29 (9) Heart failure 388 (27) 119 (36) Cardiac dysrhythmia 100 (7) 30 (9) Abnormal cardiac conduction 243 (17) 64 (19) Valvular disease/surgery 174 (12) 60 (18) Mitral stenosis 9 (1) 3 (1) Fall, N (%) 204 (14) 57 (17) 5